ATE532525T1 - Zusammensetzungen von botanischen extrakten für die krebstherapie - Google Patents

Zusammensetzungen von botanischen extrakten für die krebstherapie

Info

Publication number
ATE532525T1
ATE532525T1 AT04816850T AT04816850T ATE532525T1 AT E532525 T1 ATE532525 T1 AT E532525T1 AT 04816850 T AT04816850 T AT 04816850T AT 04816850 T AT04816850 T AT 04816850T AT E532525 T1 ATE532525 T1 AT E532525T1
Authority
AT
Austria
Prior art keywords
compositions
extract
therapeutically effective
cancer therapy
botanical extracts
Prior art date
Application number
AT04816850T
Other languages
English (en)
Inventor
James Dao
Tom Dao
David Tong
Leslie Wilson
Mary Jordan
William Gerwick
Original Assignee
Genyous Biomed Internat Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genyous Biomed Internat Inc filed Critical Genyous Biomed Internat Inc
Application granted granted Critical
Publication of ATE532525T1 publication Critical patent/ATE532525T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539—Scutellaria (skullcap)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/074—Ganoderma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AT04816850T 2003-09-08 2004-09-08 Zusammensetzungen von botanischen extrakten für die krebstherapie ATE532525T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50145603P 2003-09-08 2003-09-08
PCT/US2004/029263 WO2005044182A2 (en) 2003-09-08 2004-09-08 Compositions of botanical extracts for cancer therapy

Publications (1)

Publication Number Publication Date
ATE532525T1 true ATE532525T1 (de) 2011-11-15

Family

ID=34572738

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04816850T ATE532525T1 (de) 2003-09-08 2004-09-08 Zusammensetzungen von botanischen extrakten für die krebstherapie

Country Status (12)

Country Link
US (2) US8173177B2 (de)
EP (1) EP1663103B1 (de)
JP (2) JP5300195B2 (de)
CN (1) CN1874781B (de)
AT (1) ATE532525T1 (de)
AU (1) AU2004287358A1 (de)
CA (1) CA2538218C (de)
DK (1) DK1663103T3 (de)
ES (1) ES2373663T3 (de)
PL (1) PL1663103T3 (de)
RU (1) RU2006111441A (de)
WO (1) WO2005044182A2 (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2373663T3 (es) 2003-09-08 2012-02-07 Genyous Biomed International Inc. Composiciones de extractos botánicos para terapia de cáncer.
CA2539534A1 (en) * 2003-09-22 2005-04-07 Genyous Biomed International Inc. Hippophae rhamnoides compositions for cancer therapy
US20050196409A1 (en) * 2003-09-24 2005-09-08 James Dao Compositions of botanical extracts for treating malignancy-associated changes
JP4789082B2 (ja) * 2004-03-04 2011-10-05 学校法人日本大学 沙棘枝から抽出したエキス並びにそれを含む発ガン抑制剤及び健康食品
CA2574060C (en) * 2004-07-16 2019-06-25 Medimush A/S Immune modulating compounds from fungi
US7514085B2 (en) 2004-07-16 2009-04-07 Medimush A/S Immune modulating compounds from fungi
EP1824340A4 (de) * 2004-12-17 2009-08-05 Bionovo Inc Verfahren zur verwendung von extrakten von epimediumspezies
US7482029B2 (en) 2005-04-01 2009-01-27 Bionovo, Inc. Composition for treatment of menopause
WO2006122274A2 (en) * 2005-05-11 2006-11-16 Baystate Health Systems, Inc. Pharmaceutical formulations of rhodiola crenulata and methods of use thereof
US20060269567A1 (en) * 2005-05-16 2006-11-30 Liu Yuen Universal detoxifying composition
JP2006342103A (ja) * 2005-06-09 2006-12-21 National Cancer Center-Japan ウーロン茶葉抽出物ｏｔａｃを有効成分とする発癌抑制剤
US9072776B2 (en) 2005-06-15 2015-07-07 Glycanova As Anti-cancer combination treatment and kit-of-parts
WO2007054623A2 (en) * 2005-11-11 2007-05-18 Licentia Oy Mammalian hedgehog signaling inhiabitors
US7700136B2 (en) * 2005-11-14 2010-04-20 Bionovo, Inc. Scutellaria barbata extract for the treatment of cancer
WO2007131034A1 (en) * 2006-05-03 2007-11-15 The Regents Of The University Of Michigan Pyrimidone derivatives which are modulators of heat shock protein (hsp) 70
WO2008127302A2 (en) * 2006-10-27 2008-10-23 Genyous BioMed International, Inc. Compositions for treatment and inhibition of pain
US20080319051A1 (en) * 2007-06-22 2008-12-25 Bionovo, Inc. Liquiritigenin and derivatives as selective estrogen receptor beta agonists
US20090042818A1 (en) * 2007-06-22 2009-02-12 Bionovo, Inc. Liquiritigenin and Derivatives as Selective Estrogen Receptor Beta Agonists
US8221803B1 (en) 2007-06-25 2012-07-17 OncoNatural Solutions, Inc. Composition for prostate health
JP2010535815A (ja) * 2007-08-08 2010-11-25 バイオノボ・インコーポレーテッド モクセイ科トウネズミモチのエストロゲン性抽出物およびその使用
AU2008296136A1 (en) * 2007-09-07 2009-03-12 Bionovo. Inc. Estrogenic extracts of Scuttelaria barbata D. Don of the Labiatae Family and uses thereof
US20090068298A1 (en) * 2007-09-07 2009-03-12 Bionovo, Inc. ESTROGENIC EXTRACTS OF Astragalus membranaceus Fisch. Bge. Var. mongolicus Bge. of the Leguminosae Family AND USES THEREOF
AU2008296176A1 (en) 2007-09-07 2009-03-12 Bionovo, Inc. Estrogenic extracts of Asparagus conchinchinensis (Lour.) Merr of the Liliaceae Family and uses thereof
JP2010539086A (ja) * 2007-09-07 2010-12-16 バイオノボ・インコーポレーテッド マメ科ファミリーのクズのエストロゲン性抽出物およびその使用
EP2222321A4 (de) * 2007-11-19 2013-02-13 Bionovo Inc Therapie gegen krebs mit einem extrakt von scutellaria barbata
WO2009067555A1 (en) * 2007-11-19 2009-05-28 Bionovo, Inc. Scutellaria barbata extract and combinations for the treatment of cancer
CA2706313A1 (en) 2007-11-19 2009-05-28 Bionovo, Inc. Methods of detecting and treatment of cancers using scuttelaria barbata extract
WO2009070478A2 (en) * 2007-11-19 2009-06-04 Bionovo, Inc. A process of making purified extract of scutellaria barbata d. don
WO2009129260A2 (en) * 2008-04-14 2009-10-22 Bionovo, Inc. Calycosin and analogs thereof for the treatment of estrogen receptor beta-mediated diseases
AU2009244315A1 (en) * 2008-05-06 2009-11-12 Bionovo, Inc. Estrogenic extracts for use in treating vaginal and vulvar atrophy
CA2726982A1 (en) * 2008-06-05 2009-12-10 Bionovo, Inc. Method of quantification of multiple bioactives from botanical compositions
JP2011522822A (ja) * 2008-06-06 2011-08-04 バイオノボ・インコーポレーテッド エストロゲン受容体β媒介性病状の治療のためのダイオウ（Ｒｈｅｕｍｐａｌｍａｔｕｍ）由来のアントラキノンおよび類似体
US20100069481A1 (en) * 2008-09-03 2010-03-18 Bionovo, Inc. Methods and compositions for the treatment of cancer
WO2010129343A2 (en) * 2009-04-28 2010-11-11 Bionovo, Inc. Method of reducing fat accumulation and inducing weight loss
TWI606835B (zh) * 2010-04-23 2017-12-01 中央研究院 基於靈芝多醣之組合物及治療癌症之方法
EP2635127B1 (de) * 2010-11-04 2018-10-17 Genyous Biomed International Kombinationstherapie für prostatakrebs mit pflanzlichen zusammensetzungen und bicalutamid
US8858953B2 (en) * 2011-05-09 2014-10-14 Yu-Hwa Peter Sheng Herbal composition for treating cancer
US8765193B2 (en) * 2012-02-24 2014-07-01 Santé International, Inc. Methods for radiation protection
JP6093238B2 (ja) * 2013-05-13 2017-03-08 株式会社リンクス 放射線障害に対する造血前駆細胞回復剤
WO2014197519A1 (en) 2013-06-03 2014-12-11 Genyous Biomed International Combination therapy for prostate cancer using botanical compositions and docetaxel
WO2014197520A1 (en) * 2013-06-03 2014-12-11 Genyous Biomed International Novel formulations of botanical extracts for cancer therapy
US9789153B2 (en) 2014-07-02 2017-10-17 Hsiu-Hsien Tsai Composition for preventing cancer and treating cancer and intensifying the effects of other anticancer drugs
US20170035789A1 (en) * 2015-08-05 2017-02-09 Bill H. McAnalley Composition Of Dietary Supplements Based On Apoptosis that Support Optimal Health
KR101951203B1 (ko) * 2015-09-24 2019-02-25 주식회사 씨엔에이치코퍼레이션 생약 성분을 포함하는 호흡기암 예방 또는 치료용 조성물
CN110122232B (zh) * 2018-02-09 2022-08-05 紫云自治县长萌农业科技开发有限责任公司 一种提高山豆根种子坐果率和产量的栽培方法
JP7763509B2 (ja) * 2020-11-09 2025-11-04 ユニバーシティ－インダストリー コーオペレイション グループ オブ キョンヒ ユニバーシティ タンジンおよびダイオウの複合抽出物を含む悪液質予防または治療用組成物の製造方法
CN113759031A (zh) * 2021-05-08 2021-12-07 北京康仁堂药业有限公司 半枝莲及半枝莲组方制剂的薄层鉴定方法
CN113633732A (zh) * 2021-09-28 2021-11-12 山东大学 一种治疗肺癌的中药组合物及其制备方法和应用
CN119386498A (zh) * 2024-11-05 2025-02-07 中国农业大学 用于提取荷叶多酚的深共晶溶剂及荷叶多酚提取方法

Family Cites Families (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU577036A1 (ru) * 1974-09-16 1977-10-25 Ростовский научно-исследовательский онкологический институт Способ предоперационного лечени рака шейки матки
JPS6056924A (ja) 1983-09-09 1985-04-02 Ryoichi Ichihara 霊芝茶の製造方法
JPS60190719A (ja) * 1984-03-09 1985-09-28 Mitsui Norin Kk 抗腫瘍剤
JPS6450877A (en) * 1987-08-20 1989-02-27 Ichimaru Pharcos Inc Oxygen radical catching and removing agent
FR2633182B1 (fr) 1988-06-23 1993-07-23 Beljanski Mirko Composition pharmaceutique anticancereuse et methode d'utilisation de l'invention
ES2099099T3 (es) 1989-11-03 1997-05-16 Alexander S Sun Tratamiento herbaceo de enfermedades malignas.
JP2648720B2 (ja) * 1992-03-16 1997-09-03 有限会社日恵 サルノコシカケ科に属する担子菌類のエキスを含有する家畜 用機能食品
JPH05328947A (ja) * 1992-03-31 1993-12-14 Sankaino Chinmi:Kk 茶類錠剤
CN1079361A (zh) * 1993-04-24 1993-12-15 河南中医学院 速溶绿茶及其加工工艺
AU676947B2 (en) 1993-12-11 1997-03-27 Societe Des Produits Nestle S.A. Ice nucleating agent
CN1110571A (zh) * 1994-04-27 1995-10-25 周纯喜 一种抗癌治癌药物及其生产工艺
CN1104535A (zh) * 1994-05-25 1995-07-05 肖文生 中草药防癌保健茶及其制作方法
CN1049827C (zh) * 1994-06-06 2000-03-01 郭文峰 抗癌冲剂
GB9415492D0 (en) 1994-08-01 1994-09-21 Celltech Ltd Biological products
DE4431393C1 (de) 1994-08-25 1996-02-15 Heilscher Karl Prof Dr Sc Verfahren zur Kaltgewinnung von Sanddornbeerenölen und Sanddornbeerenmazerat mit reduziertem Fettgehalt und ihre Verwendung
CN1118263A (zh) * 1994-09-06 1996-03-13 毕盛 抗癌中成药-生命之星
CN1105588A (zh) 1994-11-02 1995-07-26 范冬锁 抗癌中药必赐康胶囊及其制造方法
RU2106859C1 (ru) 1994-12-02 1998-03-20 Сенявина Наталья Константиновна Средство для ухода за кожей
IT1275905B1 (it) 1995-03-14 1997-10-24 Indena Spa Frazioni polifenoliche di te', loro uso e formulazioni che le contengono
UA32435C2 (uk) 1995-06-29 2000-12-15 Олексій Генадійович Чистяков Крем для шкіри обличчя "talita"
CN1069036C (zh) * 1995-07-21 2001-08-01 崔景岳 灵芝仙饮
JPH09208484A (ja) 1996-01-31 1997-08-12 Pola Chem Ind Inc 活性酸素消去剤及びそれを含む組成物
RU2120272C1 (ru) 1996-02-16 1998-10-20 Товарищество с ограниченной ответственностью "Биокосметическая фабрика" Зимний косметический крем для защиты кожи
US5665393A (en) * 1996-09-03 1997-09-09 International Medical Research, Inc. Herbal composition for treating prostate carcinoma
US5910308A (en) 1997-03-19 1999-06-08 Sante International Inc. Herbal extract composition containing gynostemma pentaphyllum, crataegus pinnatifida and camellia sinensis
RU2129423C1 (ru) 1997-06-19 1999-04-27 Фролов Владимир Владимирович Мазь фролова в.в. для лечения ожогов и инфицированных ран
PT1001797E (pt) 1997-07-30 2005-08-31 Indena Spa Extracto de soja, processo para a sua preparacao e composicao farmaceutica
RU2134570C1 (ru) 1997-10-06 1999-08-20 Бенчаров Юрий Владимирович Косметический крем
EP0938897A1 (de) 1997-12-26 1999-09-01 Japanese Foundation For Cancer Research Telomerase Hemmer
JPH11246402A (ja) * 1997-12-26 1999-09-14 Japan Found Cancer Res テロメレ―ス阻害剤
RU2129003C1 (ru) 1998-04-10 1999-04-20 Гоино Тадаши Средство, обладающее противоопухолевой активностью
US6168795B1 (en) 1998-06-09 2001-01-02 Sant{acute over (e)} International Inc. Method for anticancer therapy using an herbal extract composition
CN1063959C (zh) 1998-08-10 2001-04-04 邹元生 沙棘油复合胶囊
RU2132183C1 (ru) 1998-10-16 1999-06-27 Утешев Даниил Борисович Мазь для лечения воспалительных и аллергических поражений кожи
RU2158599C2 (ru) 1998-12-10 2000-11-10 Брусенцов Николай Антонович Средство для иммунопотенцирования и нормализации тонуса при химиопрофилактике и терапии онкологических, психических, лучевых, инфекционных и простудных заболеваний
CN1232690A (zh) 1998-12-17 1999-10-27 童忠良 银杏沙棘养生茶
CN1116069C (zh) 1999-04-26 2003-07-30 罗萌 一种老年用保健口服液及其制备方法
CN1122528C (zh) 1999-05-11 2003-10-01 吴桂荣 一种复合红花油制剂及含该制剂的药物
US6299925B1 (en) 1999-06-29 2001-10-09 Xel Herbaceuticals, Inc. Effervescent green tea extract formulation
CN1099892C (zh) * 1999-07-29 2003-01-29 北京理工大学 灵芝孢子中抗肿瘤成分的分离技术
US20010012851A1 (en) * 1999-07-29 2001-08-09 Kristin M. Lundy Nitric oxide releasing oxindole prodrugs for anagesic, anti-inflammatory and disease-modifying use
US6316002B1 (en) 1999-10-12 2001-11-13 Xin Liu Germination activated red Ganoderma lucidum spores and method for producing the same
JP2001163792A (ja) 1999-12-08 2001-06-19 Koji Tanaka 滋養強壮健康増進用組成物
KR20010074416A (ko) 2000-01-25 2001-08-04 손남율 항바이러스제 및 항암제
EP1253921A4 (de) * 2000-01-28 2004-10-13 Merck & Co Inc Behandlung und prophylaxe des prostatakrebs mit cox-2 selektiven inhibitoren
KR20010083663A (ko) 2000-02-17 2001-09-01 손남율 항바이러스제 및 항암제
RU2170101C1 (ru) 2000-02-17 2001-07-10 Общество с ограниченной ответственностью Научно-производственное предприятие "БИОНОКС" Средство для лечения воспалительных заболеваний
US6399116B1 (en) 2000-04-28 2002-06-04 Rulin Xiu Rhodiola and used thereof
CN1093405C (zh) 2000-08-10 2002-10-30 重庆市康尔寿保健食品研究所 一种减肥茶
KR20020017675A (ko) * 2000-08-31 2002-03-07 김복량 발암 억제제
AU2001235965A1 (en) 2000-09-15 2002-03-26 Dabur Research Foundation Antibacterial combination comprising neem plant extract
WO2002048344A2 (en) * 2000-12-13 2002-06-20 Georgetown University Gene therapy for prostate cancer: sensibilization of cells to dn a damaging drugs and radiation
CN1305754A (zh) 2000-12-25 2001-08-01 程显峰 海参营养液及其制法
CN1296079C (zh) * 2001-02-13 2007-01-24 廖庆军 一种广谱抗癌、治癌的口服丸剂及其制备方法
CN1312116A (zh) 2001-03-07 2001-09-12 刘俊山 一种配合放化疗治疗晚期肿瘤的瘤复康口服液及制备方法
US6756063B2 (en) 2001-03-29 2004-06-29 Zoltan Laboratories, Llc Methods and compositions for the treatment of human and animal cancers
US6911221B2 (en) * 2001-04-02 2005-06-28 Hongfen Li Anti-neoplastic drug
KR20020078314A (ko) * 2001-04-09 2002-10-18 조갑환 동/식물의 약재를 이용한 건강식품 제조방법
US6576269B1 (en) 2001-09-06 2003-06-10 Alexander Y. Korneyev Treating open skin lesions using extract of sea buckthorn
JP2003183176A (ja) * 2001-10-09 2003-07-03 Wellness Movement:Kk 免疫賦活組成物
CN1413657A (zh) * 2002-10-17 2003-04-30 王长奎 一种治疗肝癌中药胶囊、药丸及制备方法
CN1187071C (zh) * 2002-12-17 2005-02-02 李天德 治疗肝癌的药物及制备方法
JP2004217545A (ja) 2003-01-10 2004-08-05 Univ Nihon 新規フラボノイド配糖体及びその用途
JP2005008539A (ja) 2003-06-17 2005-01-13 Fancl Corp マトリックスメタロプロテイナーゼ阻害剤
CN1480209A (zh) 2003-07-18 2004-03-10 陈 列 复方峰胶制剂的加工方法
ES2373663T3 (es) 2003-09-08 2012-02-07 Genyous Biomed International Inc. Composiciones de extractos botánicos para terapia de cáncer.
CA2539534A1 (en) 2003-09-22 2005-04-07 Genyous Biomed International Inc. Hippophae rhamnoides compositions for cancer therapy
US20050196409A1 (en) 2003-09-24 2005-09-08 James Dao Compositions of botanical extracts for treating malignancy-associated changes

Also Published As

Publication number Publication date
DK1663103T3 (da) 2012-01-30
US8173177B2 (en) 2012-05-08
RU2006111441A (ru) 2006-08-27
JP2013064021A (ja) 2013-04-11
EP1663103A4 (de) 2009-09-09
CA2538218C (en) 2014-11-25
JP2007505042A (ja) 2007-03-08
WO2005044182A3 (en) 2005-08-25
CN1874781A (zh) 2006-12-06
PL1663103T3 (pl) 2012-05-31
AU2004287358A1 (en) 2005-05-19
EP1663103B1 (de) 2011-11-09
CN1874781B (zh) 2010-11-10
EP1663103A2 (de) 2006-06-07
US20050208070A1 (en) 2005-09-22
JP5300195B2 (ja) 2013-09-25
CA2538218A1 (en) 2005-05-19
WO2005044182A2 (en) 2005-05-19
US20130101616A1 (en) 2013-04-25
ES2373663T3 (es) 2012-02-07

Similar Documents

Publication Publication Date Title
ATE532525T1 (de) Zusammensetzungen von botanischen extrakten für die krebstherapie
WO2008127302A3 (en) Compositions for treatment and inhibition of pain
UA85065C2 (ru) Фармацевтическая композиция для лечения кардиоваскулярных и цереброваскулярных заболеваний
HN2001000243A (es) Inhibidores de metaloproteinasa del tipo pirimidin - 2, 4, 6 - triona
IL154888A0 (en) Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid
MXPA03005666A (es) Composicion herbal para angina pectoris, metodo para preparar la misma y sus usos.
NO20031143D0 (no) Farmasöytisk sammensetning av urter og dens fremstilling
ATE494899T1 (de) Zusammensetzung bestehend aus phy906 und chemotherapeutika
SG149053A1 (en) Hippophae rhamnoides compositions for cancer therapy
NO975858L (no) Anvendelse av et ekstrakt av Cimicifuga racemosa
WO2006050155A3 (en) Cancer therapeutic compositions
CA2245123A1 (fr) Extrait de rosacees en tant qu'antagoniste de bradykinine
IL172180A (en) Use of at least one herb extract from the genus equisetum and at least one film forming agent for the preparation of topical compositions for treating onychoschizia
NO20015338D0 (no) Androgenderivater og anvendelse derav
EP1558282A4 (de) Zusammensetzungen gegen krebs und infektionskrankheiten und anwendungsverfahren dafür
ITMI20011837A0 (it) Estratti dal fungus guignardia sp., loro impiego nelle composizioni farmaceutiche,nuovo composto isolato dall'estratto del fungus guignardia
EP1945034A4 (de) Kräuterpulverextrakte und verfahren zu ihrer herstellung und anwendung
TR200002847T2 (tr) Biçim VI 5, 6-dikloro-2-(izopropilamino) -1-(beta-L-ribofüranosil) -1H-benzimidazol.
AR029451A1 (es) Una composicion para su uso en la terapia del cancer de mamas en seres humanos y un producto para su uso en dicha terapia
CY1107227T1 (el) Θεραπεια αυτοανοσων νοσων με εκχυλισμα αμερικανικου γκινσενγκ
DE50005714D1 (de) Pharmazeutische zusammensetzung, umfassend eukalyptus- und orangenöl
AU7548901A (en) Liposomal encapsulation of chelated actinium-225 and uses thereof
EP1848450A4 (de) Kräutermischungsextrakt aus pleurotus eryngii, acanthopanacis cortex und notoginseng radix sowie zusammensetzung damit zur verhinderung und behandlung von periodontitis
ES2189923T3 (es) Uso de un extracto que contiene flavonoides de la planta euphorbia prostata en la preparacion de un medicamento para el tratamiento de desordenes anorectales y del colon.
Toda et al. Comparisons of Antioxidative and Chelating effects of Daidzein and Daidzin

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1663103

Country of ref document: EP